Role of Tissue Inhibitors of Matrix Metalloproteases-1 (TIMP-1) in Evolution of CCl4-Induced Liver Cirrhosis in Mice.

Document Type : Original Article

Authors

1 Department of Histology, Faculty of Medicine, Sohag University, Egypt.

2 Department of histology, Faculty of medicine, Sohag university.

3 Department of surgery, Faculty of medicine, Sohag university.

Abstract

Background
Cirrhosis is a worldwide end stage liver disease. It is characterized by diffuse fibrosis and conversion of normal liver lobules into structurally abnormal nodules.
Aim of the work
This study was conducted to investigate the role of tissue inhibitors of matrix metalloproteases-1 (TIMP-1) in during the evolution of cirrhosis, and in fibers resolution after cessation of the insult.
Materials and methods
54 adult male Balb/c mice; about 2 months old were randomly divided into control and treated groups;Control:24 animals.In the treated groups; 30 animals were subcutaneously injected with CCl4 (20% # diluted in sunflower oil) in a dose of 1 ml per Kg twice weekly.6 animals of them were sacrificed72 hours after the last dose at the 4th week, 8th week, 12th week, and 16th week.6 animals were kept for two weeks without injection after the 16 weeks of CCl4 treatment.
Results                                                                                                             
Our results indicated that TIMP-1 is involved in the process of fibrogenesis and fibers resolution in an experimental model of cirrhosis in mice.
Conclusion
TIMP-1 is involved in the process of fibrogenesis in mice which can be applied in new strategies for the treatment of liver cirrhosis.

Keywords


  1. Abdelmegeed, M. A., Choi, Y., Godlewski, G., Ha, S.-K., Banerjee, A., Jang, S., & Song, B.-J. (2017): Cytochrome P450-2E1 promotes fast food-mediated hepatic fibrosis. Scientific Reports; 7: 39764
  2. Domitrović R, Jakovac H, Tomac J, Sain I. (2009): Liver fibrosis in mice induced by carbon tetrachloride and its reversion by luteolin. Toxicology and Applied Pharmacology; 241: 311–321
  3. Iredale, J.P., Benyon, R.C., Pickering, J., McCullen, M., Northrop, M., Pawley, S., Hovell, C., Arthur,  M.J.,  (1998):  Mechanisms  of  spontaneous  resolution  of  rat  liver  fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J. Clin. Invest. 102, 538–549.
  4. Jang JH, Kang KJ, Kim YH, Kang YN, Lee IS. ( (2008): Reevaluation of Experimental Model of Hepatic Fibrosis Induced by Hepatotoxic Drugs: An Easy, Applicable, and Reproducible Model.Transplantation Proceedings, 40, 2700–2703.
  5. Kang JS1, Morimura K, Salim EI, Wanibuchi H, Yamaguchi S, Fukushima S.(2005): Persistence of liver cirrhosis in association with proliferation of nonparenchymal cells and altered location of alpha-smooth muscle actin-positive cells. Toxicol Pathol.;33(3):329-35.
  6. Kim K.  H., Burkhart  K.,  Chen,  P.,  Frevert,  C.  W., Randolph-Habecker,  J., Hackman,  R.  C., Soloway, P.  D. and Madtes, D.  K. (2005):  Tissue inhibitor  of metalloproteinase-1  deficiency  amplifies  acute  lung  injury  in  bleomycin-exposed mice. Am. J. Respir. Cell Mol. Biol. 33, 271-279.
  7. Liu CY1, Gu ZL, Zhou WX, GuoCY(2005): Effect of Astragaluscomplanatus flavonoid on anti-liver fibrosis in rats. World J Gastroenterol. ;11(37):5782-6.
  8. Nie, Q.-H., Duan, G.-R., Luo, X.-D., Xie, Y.-M., Luo, H., Zhou, Y.-X., & Pan, B.-R. (2004) Expression of TIMP-1 and TIMP-2 in rats with hepatic fibrosis. World Journal of Gastroenterology, 10(1), 86–90.
  9. Robert S, Gicquel T, BodinA, Lagente V, Boichot E (2016): Characterization of the MMP/TIMP Imbalance and Collagen Production Induced by IL-1 β or TNF- α Release from Human Hepatic Stellate Cells. PLoS ONE 11(4): e0153118.
  10. Vaillant, B., Chiaramonte, M. G., Cheever, A. W., Soloway, P. D. and Wynn, T. A.(2001).  Regulation  of  hepatic  fibrosis  and  extracellular  matrix  genes  by  the  response: new insight into the role of tissue inhibitors of matrix metalloproteinases.J. Immunol. 167, 7017-7
  11. VanheuleE ,. Geerts A.M , Huysse J.V , Schelfhout D, Praet M, Vlierberghe H.V, Vos M.D , Colle I(2008) : An intravital microscopic study of the hepatic microcirculation in cirrhotic mice models: relationship between fibrosis and angiogenesis. Int. J. Exp. Path. ;89, 419–432.
  12. Wang H., Lafdil, F., Wang, L., Yin, S., Feng, D. and Gao, B. (2011): Tissue inhibitor of metalloproteinase 1 (TIMP-1) deficiency exacerbates carbon tetrachloride-induced liver  injury  and  fibrosis  in  mice:  involvement  of  hepatocyte  STAT3  in  TIMP-1 production. Cell Biosci 1, 14.
  13. Woessner, J.F., (1991). Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J. 5, 2145–2154.
  14. Yoshiji,  H.,  Kuriyama,  S.,  Yoshii,  J.,  Ikenaka,  Y.,  Noguchi,  R.,  Nakatani,  T.,Tsujinoue, H., Yanase, K., Namisaki, T., Imazu, H. et al. (2002): Tissue inhibitor of metalloproteinases-1   attenuates   spontaneous   liver   fibrosis   resolution   in   the transgenic mouse. Hepatology 36, 850-860.
  15. ZakiMM ,Ataa HM, Shenouda HD, Yousef MM, and Ahmed NE(2011): Effect of mesenchymal stem cells administered by two different  routes on experimentally induced liver fibrosis in rats Egypt J Histol 34: 780-789.